搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medindia
12 小时
Constipation: A Warning Sign of Cancer That You Shouldn't Ignore
Can chronic constipation indicate cancer? Learn how to recognize warning signs, take early action, and protect your health.
来自MSN
12 小时
Baby Not Pooping But Passing Gas: Causes & How To Help Them
The bowel movements of an infant are an important measure of their overall health. The regularity with which a baby poops ...
Newspoint on MSN
1 小时
10 Must Try Home Remedies To Get Rid of Hernia
A hernia occurs when an internal organ or tissue pushes through a weak spot in the surrounding muscle or connective tissue.
1 小时
on MSN
Discover the surprising natural remedies for gut health that you haven't tried yet!
Castor oil packs and mud packs can enhance gut health by improving digestion, reducing bloating, and promoting detoxification ...
14 小时
on MSN
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
Medindia
21 小时
Exploring the Role of the Gut in Parkinson's Disease
Parkinson’s disease may start in the gut, with gastrointestinal symptoms like constipation appearing years before ...
13 小时
on MSN
The first US drug treatment for sleep apnea approved; all you want to know
The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...
Medscape
19 小时
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
18 分钟
NHS warns symptoms of cancer women can experience while eating
There is a significant overlap between some symptoms of ovarian cancer, irritable bowel syndrome (IBS) and premenstrual ...
23 小时
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has received an average rating of “Moderate Buy” from the five ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈